56 related articles for article (PubMed ID: 31241180)
1. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Morimoto J; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Matsubara H; Yoshino I; Kaneda A
Int J Cancer; 2020 Jan; 146(2):388-399. PubMed ID: 31241180
[TBL] [Abstract][Full Text] [Related]
2. Global methylation patterns in idiopathic pulmonary fibrosis.
Rabinovich EI; Kapetanaki MG; Steinfeld I; Gibson KF; Pandit KV; Yu G; Yakhini Z; Kaminski N
PLoS One; 2012; 7(4):e33770. PubMed ID: 22506007
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
4. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.
Yang IV; Pedersen BS; Rabinovich E; Hennessy CE; Davidson EJ; Murphy E; Guardela BJ; Tedrow JR; Zhang Y; Singh MK; Correll M; Schwarz MI; Geraci M; Sciurba FC; Quackenbush J; Spira A; Kaminski N; Schwartz DA
Am J Respir Crit Care Med; 2014 Dec; 190(11):1263-72. PubMed ID: 25333685
[TBL] [Abstract][Full Text] [Related]
5. Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Ding X; Liu H; Xu Q; Ji T; Chen R; Liu Z; Dai J
Int Immunopharmacol; 2024 Jun; 134():112162. PubMed ID: 38703565
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in lung fibrosis: from pathobiology to treatment perspective.
Helling BA; Yang IV
Curr Opin Pulm Med; 2015 Sep; 21(5):454-62. PubMed ID: 26176965
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
[TBL] [Abstract][Full Text] [Related]
8. Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.
Theelen WSME; Krijgsman O; Monkhorst K; Kuilman T; Peters DDGC; Cornelissen S; Ligtenberg MA; Willems SM; Blaauwgeers JLG; van Noesel CJM; Peeper DS; van den Heuvel MM; Schulze K
J Transl Med; 2020 Jul; 18(1):271. PubMed ID: 32620126
[TBL] [Abstract][Full Text] [Related]
9. On Predicting lung cancer subtypes using 'omic' data from tumor and tumor-adjacent histologically-normal tissue.
Pineda AL; Ogoe HA; Balasubramanian JB; Rangel Escareño C; Visweswaran S; Herman JG; Gopalakrishnan V
BMC Cancer; 2016 Mar; 16():184. PubMed ID: 26944944
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma.
Cai Q; He B; Tu G; Peng W; Shi S; Qian B; Liang Q; Peng S; Tao Y; Wang X
iScience; 2023 Jul; 26(7):107013. PubMed ID: 37389184
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation.
Gan J; Zhang Y; Liu S; Mu G; Zhao J; Jiang W; Li J; Li Q; Wu Y; Wang X; Che D; Li X; Huang X; Meng Q
Cell Death Discov; 2023 Jun; 9(1):199. PubMed ID: 37385985
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation.
Effendi WI; Nagano T
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189665
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets.
Xia J; Li S; Liu S; Zhang L
MedComm (2020); 2023 Feb; 4(1):e195. PubMed ID: 36694633
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis and experimental validation identified DNA methylation-Related biomarkers and immune-cell infiltration of atherosclerosis.
Xu C; Sun D; Wei C; Chang H
Front Genet; 2022; 13():989459. PubMed ID: 36159969
[No Abstract] [Full Text] [Related]
15. CFTR and Gastrointestinal Cancers: An Update.
Bhattacharya R; Blankenheim Z; Scott PM; Cormier RT
J Pers Med; 2022 May; 12(6):. PubMed ID: 35743652
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation in pulmonary fibrosis and lung cancer.
Duan J; Zhong B; Fan Z; Zhang H; Xu M; Zhang X; Sanders YY
Expert Rev Respir Med; 2022 May; 16(5):519-528. PubMed ID: 35673969
[TBL] [Abstract][Full Text] [Related]
17. The impact of
Lu HJ; Chuang CY; Chen MK; Su CW; Yang WE; Yeh CM; Lai KM; Tang CH; Lin CW; Yang SF
Aging (Albany NY); 2022 May; 14(10):4556-4571. PubMed ID: 35613852
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein 1M (MT1M) inhibits lung adenocarcinoma cell viability, migration, and expression of cell mobility-related proteins through MDM2/p53/MT1M signaling.
Xu W; Jiang GJ; Shi GZ; Chen MZ; Ma TL; Tan YF
Transl Cancer Res; 2020 Apr; 9(4):2710-2720. PubMed ID: 35117630
[TBL] [Abstract][Full Text] [Related]
19. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
[TBL] [Abstract][Full Text] [Related]
20. Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in
Schamschula E; Lahnsteiner A; Assenov Y; Hagmann W; Zaborsky N; Wiederstein M; Strobl A; Stanke F; Muley T; Plass C; Tümmler B; Risch A
Epigenetics; 2022 Aug; 17(8):837-860. PubMed ID: 34415821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
